Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]

Letter/Communication

Peer reviewed

Journal of Gastroenterology and Hepatology (Australia), Vol.19(6), pp.723-724

19

06/2004

PMID: 15151639

Abstract

Hepatology

Gastroenterology

4 Record Views

Title: Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C [6]
Creators: Sandeep Mukherjee (Author) - University of Nebraska Medical Center
Publication Details: Journal of Gastroenterology and Hepatology (Australia), Vol.19(6), pp.723-724
Series: 19
Number of pages: 2
Identifiers: 991005928986302656
Academic Unit: Creighton University
Language: English
Resource Type: Letter/Communication